These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 23843441

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.
    Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA.
    J Natl Cancer Inst; 2014 Mar; 106(3):djt456. PubMed ID: 24563519
    [Abstract] [Full Text] [Related]

  • 4. Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissue.
    Roy S, Brasky TM, Belury MA, Krishnan S, Cole RM, Marian C, Yee LD, Llanos AA, Freudenheim JL, Shields PG.
    Int J Cancer; 2015 Dec 15; 137(12):2934-46. PubMed ID: 26137879
    [Abstract] [Full Text] [Related]

  • 5. Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer.
    Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, Harris W.
    Nutr Cancer; 2015 Dec 15; 67(4):543-54. PubMed ID: 25826711
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    El-Bayoumy K, Thompson H, Manni A.
    J Natl Cancer Inst; 2014 Apr 15; 106(4):dju017. PubMed ID: 24685921
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Cleland LG, Proudman SM, James MJ.
    J Natl Cancer Inst; 2014 Apr 15; 106(4):dju022. PubMed ID: 24685932
    [No Abstract] [Full Text] [Related]

  • 10. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    McCarty MF, Dinicolantonio JJ, Lavie CJ, O'Keefe JH.
    J Natl Cancer Inst; 2014 Apr 15; 106(4):dju014. PubMed ID: 24685931
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Harris WS, Davidson MH.
    J Natl Cancer Inst; 2014 Apr 15; 106(4):dju019. PubMed ID: 24685928
    [No Abstract] [Full Text] [Related]

  • 13. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Brenna JT, Burdge GC, Crawford MA, Clayton P, Cunnane SC, Gow R, Hibbeln JR, Sinclair AJ, Stein J, Willatts P.
    J Natl Cancer Inst; 2014 Apr 15; 106(4):dju015. PubMed ID: 24685922
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, Lucia MS, Kristal AR.
    JAMA Oncol; 2015 Jun 15; 1(3):342-9. PubMed ID: 26181184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.